Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide in Liver Transplantation
NCT03315052Phase 4Withdrawn
- Sponsor
- Montefiore Medical Center
- Start
- Jan 2019
- Primary completion
- Jan 2021
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of EPI-EE in Liver transplant rejection, sponsored by Montefiore Medical Center. Planned start Jan 2019; status: withdrawn.
02
Drugs
EPI-EE
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT03315052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03315052.